Cargando…
Development of Biomarkers and Molecular Therapy Based on Inflammatory Genes in Diabetic Nephropathy
Diabetic Nephropathy (DN) is a debilitating consequence of both Type 1 and Type 2 diabetes affecting the kidney and renal tubules leading to End Stage Renal Disease (ESRD). As diabetes is a world epidemic and almost half of diabetic patients develop DN in their lifetime, a large group of people is a...
Autor principal: | Maiti, Amit K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465809/ https://www.ncbi.nlm.nih.gov/pubmed/34576149 http://dx.doi.org/10.3390/ijms22189985 |
Ejemplares similares
-
Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy
por: Lv, Jiarong, et al.
Publicado: (2020) -
Inflammatory Targets in Diabetic Nephropathy
por: Donate-Correa, Javier, et al.
Publicado: (2020) -
Tubulointerstitial Biomarkers for Diabetic Nephropathy
por: Satirapoj, Bancha
Publicado: (2018) -
Inflammatory Cytokines in Diabetic Nephropathy
por: Donate-Correa, Javier, et al.
Publicado: (2015) -
Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
por: Mu, Xiaodie, et al.
Publicado: (2022)